Sirio Pharma Co., Ltd. (SHE:300791)

Market Cap	7.19B
Revenue (ttm)	4.21B
Net Income (ttm)	330.67M
Shares Out	305.65M
EPS (ttm)	1.09
PE Ratio	21.57
Forward PE	18.36
Dividend	0.50 (2.13%)
Ex-Dividend Date	May 27, 2025

Volume	2,450,703
Average Volume	4,021,656
Open	23.10
Previous Close	23.42
Day's Range	23.10 - 23.68
52-Week Range	16.32 - 28.19
Beta	0.57
RSI	48.60
Earnings Date	Aug 26, 2025

About Sirio Pharma

Sirio Pharma Co., Ltd. operates as a contract manufacturer for dietary supplement industry worldwide. The company develops and manufactures a range of softgel dietary supplements; vegetarian softgel; nutritious gummies; probiotic balls; tablet and powder products; capsules; and functional beverages. It also offers a range of services, including primary and final packaging. Sirio Pharma Co., Ltd. was founded in 1993 and is based in Shantou, China.

• Industry: Packaged Foods
• Sector: Consumer Staples
• Founded: 1993
• Employees: 2,776
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300791

Financial Performance

In 2024, Sirio Pharma's revenue was 4.21 billion, an increase of 17.56% compared to the previous year's 3.58 billion. Earnings were 325.06 million, an increase of 15.66%.